Client News

InflaRx to Present New Preclinical Data on INF904 at the 19th European Meeting on Complement in Human Diseases

Formycon announces start of clinical phase III trial for Keytruda® biosimilar candidate FYB206

Formycon and Fresenius Kabi Receive Positive CHMP Opinion for FYB202 (Ustekinumab), a Biosimilar Candidate to Stelara®

Andera Partners Co-Leads $196 Million Round for Kestra Medical and Welcomes Raymond W. Cohen to Board of Directors

Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience

Andera Partners’ Portfolio Company JenaValve Technology Acquired by Edwards Lifesciences

Andera Partners’ Portfolio Company TRiCares Secures $50 Million in Series D Financing to Support Upcoming Clinical Milestones

CARBIOS and Nouvelles Fibres Textiles Cooperate to Develop the French Polyester Textile Recycling Industry

AATec Medical Reports Significant Progress in Company’s First Year towards Unlocking the Therapeutic Potential of AAT

Volta Medical Enters into Joint Development Agreement with GE HealthCare to Enhance Arrhythmia Procedures with AI-Driven Electrophysiology Technologies